Beyond tamoxifen - Extending endocrine treatment for early-stage breast cancer

被引：13

作者：

Burstein, HJ ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Boston, MA USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 349卷 / 19期

关键词：

D O I：

10.1056/NEJMe038174

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1857 / 1859

页数：3

共 11 条

[1]

BRYANT J, 2001, J NATL CANC I MONOGR, V30, P56

[2]

Clarke M, 1998, LANCET, V351, P1451

[3] Five versus more than five years of tamoxifen for lymph node-negative breast cancer: Updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial [J].

Fisher, B ;

Dignam, J ;

Bryant, J ;

Wolmark, N .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (09) :684-690

[4] Meeting highlights:: Updated international expert consensus on the primary therapy of early breast cancer [J].

Goldhirsch, A ;

Wood, WC ;

Gelber, RD ;

Coates, AS ;

Thürlimann, B ;

Senn, HJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (17) :3357-3365

[5] A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer [J].

Goss, PE ;

Ingle, JN ;

Martino, S ;

Robert, NJ ;

Muss, HB ;

Piccart, MJ ;

Castiglione, M ;

Tu, D ;

Shepherd, LE ;

Pritchard, KI ;

Livingston, RB ;

Davidson, NE ;

Norton, L ;

Perez, EA ;

Abrams, JS ;

Therasse, P ;

Palmer, MJ ;

Pater, JL .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (19) :1793-1802

[6]

National Institutes of Health Consensus Development Panel, 2001, J Natl Cancer Inst Monogr, P5

[7] Drug therapy - Tamoxifen in the treatment of breast cancer [J].

Osborne, CK .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (22) :1609-1618

[8] Drug therapy: Aromatase inhibitors in breast cancer [J].

Smith, IE ;

Dowsett, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (24) :2431-2442

[9] Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years [J].

Stewart, HJ ;

Prescott, RJ ;

Forrest, APM .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (06) :456-462

[10] Postchemotherapy adjuvant tamoxifen therapy beyond five years in patients with lymph node-positive breast cancer [J].

Tormey, DC ;

Gray, R ;

Falkson, HC .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (24) :1828-1833

← 1 2 →